CXCR2 and prostate neoplasm: Pharmacological inhibition of CXCR2 was able to drive macrophages towards a pro-inflammatory state that induced growth arrest and senescence, specifically in prostate tumours deprived of PTEN expression (Di Mitri et al. 2019).